Share this article
BRONX, N.Y., Feb. 18, 2021 /PRNewswire/
Last December, 70-year-old Bronx resident Irma Vega got COVID-19. Like 52 percent of people living in the Bronx, Vega had multiple chronic conditions, meaning her case of COVID-19 could easily become life-threatening. After her positive test, she arrived at Montefiore Medical Center to begin monoclonal antibody treatment.
Dr. Priya Nori, director of the Antibiotic Stewardship Program, an infectious disease specialist at Montefiore Health System, and associate professor of medicine at Albert Einstein College of Medicine
Monoclonal antibodies are created in a lab and function like naturally occurring antibodies, fighting infections before they spread. Studies show that when monoclonal antibodies are given intravenously to high-risk people diagnosed early with COVID-19, it can prevent them from experiencing severe symptoms that lead to hospitalizations.